The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,746.00
Bid: 4,732.00
Ask: 4,736.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.085%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,746.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Dec 2019 07:00

RNS Number : 8814W
Croda International PLC
16 December 2019
 

16 December 2019

 

Croda International Plc

 

Appointment of Non-Executive Director - Board succession planning

 

The Board of Croda International Plc is pleased to announce the appointment of John Ramsay as a Non-Executive Director with effect from 1 January 2020.

 

John, a Chartered Accountant, served as Chief Financial Officer of Syngenta AG from 2007 to 2016 and was also Interim Chief Executive Officer from October 2015 to June 2016. Prior to this, John served as Group Financial Controller of Syngenta from 2000 to 2007 and as the Finance Head of Asia Pacific for Zeneca Agrochemicals from 1993 to 1999. Earlier in his career he was a Financial Controller of ICI Malaysia and regional controller for Latin America. Before joining ICI in 1984, he worked in audit and tax at KPMG. John is a member of the Supervisory Board at Koninklijke DSM N.V. and a Non-Executive Director of G4S plc and RHI Magnesita N.V. He is Audit Committee Chair on all three boards.

 

On joining the Board, John will be appointed to the Audit, Nomination and Remuneration Committees.

 

Alan Ferguson will retire from the Board on 23 April 2020 following the AGM after nine years as a Non-Executive Director. John Ramsay will take over as Chair of the Audit Committee and Helena Ganczakowski will take on the role as Senior Independent Director. Helena has been on the Board since February 2014 and is the Chair of the Remuneration Committee.

 

Anita Frew, Chair of Croda International Plc, commented:

 

"John brings with him a wealth of financial, international and sector experience. John has a Life Sciences background with ICI, AstraZeneca and Syngenta and brings a deep emerging market experience from his 10 years living and working in Asia and from his work in Latin America. We are delighted to welcome him to the Board. John's appointment in January 2020 will allow for a period of hand over before he takes the role as Audit Committee Chair in April 2020. His strong background as an Audit Committee Chair will be of enormous benefit to the Croda Board and complement and enhance the significant expertise we already have on the Board.

 

"I am delighted that Helena Ganczakowski is stepping up to become Senior Independent Director. She has extensive Board experience and has demonstrated strong leadership of the Remuneration Committee.

 

"Alan Ferguson has made an outstanding contribution to the Board, both as Audit Committee Chair and Senior Non-Executive Director, and, on behalf of the Board and his colleagues, we thank him for all his advice and support and wish him all the best for the future."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

 

 

Enquiries:

 

Jez Maiden, Group Finance Director, Croda International Plc

investor.relations@croda.com

+44 (0)1405 860551

 

Charlie Armitstead, Teneo

charles.armitstead@teneo.com 

+44 (0)7703 330 269

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMMMMZKFNGLZM
Date   Source Headline
7th Oct 20227:00 amRNSInvestor seminar
5th Oct 20224:42 pmRNSDirector/PDMR Shareholding
20th Sep 20229:01 amRNSDirector/PDMR Shareholding
13th Sep 20221:47 pmRNSDirector/PDMR Shareholding
11th Aug 20222:39 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSResults for the six months ended 30 June 2022
22nd Jul 20224:50 pmRNSDirectorate Change
12th Jul 20223:08 pmRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSCompleted divestment
30th Jun 202212:15 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSUS Government to support lipid systems expansion
22nd Jun 20229:07 amRNSHolding(s) in Company
17th Jun 20229:46 amRNSHolding(s) in Company
13th Jun 20222:52 pmRNSDirector/PDMR Shareholding
8th Jun 202211:53 amRNSDirector/PDMR Shareholding
7th Jun 20225:23 pmRNSTransaction in Own Shares
7th Jun 20224:08 pmRNSDirector/PDMR Shareholding
7th Jun 20223:27 pmRNSHolding(s) in Company
27th May 202210:48 amRNSHolding(s) in Company
26th May 20227:02 amRNSDirector Declaration
23rd May 20222:34 pmRNSResult of AGM
20th May 20227:21 amRNSAGM trading update
19th May 20223:09 pmRNSDirector/PDMR Shareholding
19th May 20222:17 pmRNSHolding(s) in Company
11th May 20222:15 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSSite visit and investor presentation
3rd May 202210:21 amRNSDirector/PDMR Shareholding
13th Apr 20229:48 amRNSDirector/PDMR Shareholding
7th Apr 20226:15 pmRNSDirector/PDMR Shareholding
31st Mar 20223:12 pmRNSUK Government to support lipid systems expansion
29th Mar 20227:00 amRNSInvestor seminar
22nd Mar 20226:14 pmRNSAnnual Financial Report
22nd Mar 20224:49 pmRNSDirector/PDMR Shareholding
16th Mar 20225:21 pmRNSDirector/PDMR Shareholding
16th Mar 20225:20 pmRNSDirector/PDMR Shareholding
16th Mar 20225:19 pmRNSDirector/PDMR Shareholding
16th Mar 20225:15 pmRNSDirector/PDMR Shareholding
16th Mar 20225:15 pmRNSDirector/PDMR Shareholding
16th Mar 20225:13 pmRNSDirector/PDMR Shareholding
16th Mar 20225:11 pmRNSDirector/PDMR Shareholding
16th Mar 20225:11 pmRNSDirector/PDMR Shareholding
16th Mar 20225:04 pmRNSDirector/PDMR Shareholding
16th Mar 20225:03 pmRNSDirector/PDMR Shareholding
15th Mar 202211:24 amRNSDirector/PDMR Shareholding
11th Mar 20222:25 pmRNSDirector/PDMR Shareholding
10th Mar 20221:10 pmRNSDirector/PDMR Shareholding
3rd Mar 202211:27 amRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSResults for the year ended 31 December 2021
11th Feb 20222:26 pmRNSDirector/PDMR Shareholding
25th Jan 202210:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.